Prexige news from FiercePharma
NewsSPOTLIGHT: Prexige gets the boot in UK, Germany
Drug regulators in the UK, Germany, and Austria have suspended Novartis' license to sell Prexige, an arthritis drug linked to possible liver damage. Read more...
Wyeth CEO: FDA creating monopoly meds
U.S. drug regulators aren't playing fair, says outgoing Wyeth CEO Bob Essner. New meds that should be allowed on the market--because they're safe and effective--are Read more...
Novartis gains Aclasta, loses Prexige
From the good news, bad news file: Novartis got the EU's approval to sell its new osteoporosis drug Aclasta, known in the U.S. as Reclast. Reclast Read more...
Diabetes drugs linked to fracture risk
One more strike against diabetes drugs. Australia's regulators are warning that the class of drugs including Avandia and Actos may boost the risk of bone fractures in older women. A four-year study Read more...
FDA rejects embattled Novartis drug
Is expected bad news better than unexpected bad? Ask Novartis. Today the company announced the FDA's rejection of the Cox-2 painkiller Prexige--a thumbs-down that Read more...
SPOTLIGHT: Vasella doubtful of Prexige approval
The FDA probably won't approve the Novartis painkiller Prexige now that it's faced regulatory action in Read more...
ALSO NOTED: New Zealand bans high dose of Prexige; Merck, Newron continue safinamide development;
> Add New Zealand to the list of countries banning high doses of Prexige, Novartis' Cox-2 inhibitor that's been linked to liver damage. Both 200 mg and 400 mg strengths will be pulled from the Read more...
| Press ReleasesPRESS RELEASE: Health Canada/Information Update: New Safety Information Regarding Prexige (Lumiracoxib)Health Canada/Information Update: New Safety Information Regarding Prexige (Lumiracoxib) OTTAWA, Aug. 16 -- Health Canada is currently requesting and reviewing new safety information regarding Read more... |
Get more Prexige coverage at:
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends